By Trend News Line 2024-04-01 20:49:04.
**Rising Cases of Mpox in the U.S. Highlight the Importance of Vaccination**
You may also like to watch : Who Is Kamala Harris? Biography - Parents - Husband - Sister - Career - Indian - Jamaican Heritage
The United States has seen a concerning increase in the number of mpox cases so far in 2024, with over 570 cases reported. This number is nearly double the amount seen at the same time last year. While the current infection rate is not as high as during the peak of the mpox outbreak in August 2022, it serves as a reminder that the virus is still circulating and poses a risk to those who are not vaccinated.
**Importance of Vaccination**
The most commonly used mpox vaccine in the U.S. is JYNNEOS, which is administered in two doses, one month apart. Full vaccination is achieved two weeks after the second dose, and no booster shots are currently recommended. It is crucial for those at risk of infection to get vaccinated. Eligibility for the vaccine and information on where to receive it can be found on the Centers for Disease Control and Prevention (CDC) website, as well as through local health departments such as those in New York City and San Francisco.
**Targeted Vaccination Efforts**
You may also like to watch: Is US-NATO Prepared For A Potential Nuclear War With Russia - China And North Korea?
The mpox vaccine is not recommended for everyone, but rather for select groups considered to be at higher risk of infection. For example, gay and bisexual men who have recently been diagnosed with a sexually transmitted infection (STI) are eligible for the vaccine. Dr. Jenni McQuiston, from the CDC’s High-Consequence Pathogens and Pathology division, emphasized that most reported cases are among individuals who are either unvaccinated or partially vaccinated.
**Understanding Mpox**
Mpox, formerly known as monkeypox, is caused by a virus related to the variola virus, which causes smallpox. There are two main types of mpox viruses, clade I and clade II, with clade I being more likely to cause severe and fatal disease. While clade I has not been detected in the U.S. so far, there is a possibility of the virus being brought into the country by travelers from regions such as the Democratic Republic of the Congo. The JYNNEOS vaccine provides protection against both clades of the virus.
**Symptoms and Risks**
Mpox infection can lead to symptoms resembling the flu, including fever, muscle aches, fatigue, and swollen lymph nodes. The characteristic pox rashes associated with the virus can vary in appearance and severity, typically starting as discolored patches and progressing to raised bumps, blisters, and scabs. Individuals with weakened immune systems, infants, those with a history of eczema, and pregnant individuals are at a higher risk of developing severe disease from mpox.
**Current Situation**
Since the mpox outbreak began in the U.S. in May 2022, over 30,000 cases have been reported, with the majority occurring in 2022. By early 2023, infection rates had decreased, but this year has seen a resurgence, with 576 cases reported in the first few months alone. The CDC emphasizes the importance of continued vigilance and vaccination efforts to prevent the spread of the virus.
**Encouraging Vaccination**
Despite the availability of the mpox vaccine, vaccination rates among at-risk groups, including gender-diverse and transgender individuals and men who have sex with men, remain below ideal levels. Health officials are urging those who are eligible for the vaccine to get vaccinated to protect themselves and others. Dr. Brandy Darby, from the Virginia Department of Health, highlighted the importance of vaccination ahead of Pride season in June to ensure that individuals can safely participate in celebrations without the risk of mpox.
In conclusion, the rising cases of mpox in the U.S. underscore the ongoing threat posed by the virus and the importance of vaccination in protecting against infection. Stay informed, stay safe, and get vaccinated to help prevent the spread of mpox..
– Mpox cases on the rise according to CDC
– Significant increase in Mpox cases reported by CDC.
